结论与氨氯地平相比，伊贝沙坦不仅在降压上有明显疗效，而且有较好的安全性和耐受性。
Conclusion Compared with amlodipine, irbesartan not only has obvious effect on lowering blood pressure, but also has better safety and toleration.
目的：评价伊贝沙坦合用依那普利对原发性高血压患者早期肾功能损害的有效性和安全性。
AIM: To evaluate the efficacy and safety of the combination of irbesartan and enalapril in treating renal damage in hypertensive patients.
目的：观察伊贝沙坦对良性小动脉性肾硬化蛋白尿的效应。
Objective: To observe the effect of irbesartan on proteinuria in benign arteriolar nephrosclerosis patients.
目的：比较伊贝沙坦和氯沙坦治疗轻中度高血压病的临床疗效、安全性及治疗依从性。
Objective: to compare the effects, safety and therapeutic dependence of irbesartan with that of losartan on mild-to-moderate essential hypertension.
目的探讨伊贝沙坦对原发性高血压(EH)患者血管内皮功能的保护作用。
Objective it is to discuss the protection of Irbesartan on endothelial function of blood vessel in patients with essential hypertension (EH).
目的比较伊贝沙坦与卡托普利治疗老年慢性心力衰竭(CHF)的临床疗效及安全性。
Objective to compare the clinical efficacy and safety of irbesartan with that of captopril in the treatment for elderly patients with congestive heart failure (CHF).
目的为了探讨原发性高血压患者伊贝沙坦降压疗效的影响因素。
Objective to evaluate the risk factors of Irbesartan in treatment of essential hypertension and to explore individualized antihypertensive treatment.
目的为了探讨原发性高血压患者伊贝沙坦降压疗效的影响因素。
Objective to evaluate the risk factors of Irbesartan in treatment of essential hypertension and to explore individualized antihypertensive treatment.
应用推荐